An Open Label Study of Solifenacin Succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Israt Jahan, Camille Vaughan, Marian Evatt, Kelly Sullivan, Carlos Singer, Raul Ordorica, Theresa Zesiewicz
Kelly L. Sullivan

URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo-Controlled Trial of Solifenacin succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Theresa Zesiewicz, Marian Evatt, Israt Jahan, Camille Vaughan, Carlos Singer, Raul Ordorica, Kelly Sullivan
Kelly L. Sullivan

Randomized, Controlled Pilot Trial of Solifenacin Succinate for Overactive Bladder in Parkinson's Disease, Theresa A. Zesiewicz, Marian Evatt, Camille P. Vaughan, Israt Jahan, Carlos Singer, Raul Ordorica, Jason L. Salemi, Jessica D. Shaw, Kelly L. Sullivan, Non-Motor Working Group of the Parkinson Study Group
Epidemiology Faculty Publications

Randomized, Controlled Pilot Trial of Solifenacin Succinate for Overactive Bladder in Parkinson's Disease, Theresa A. Zesiewicz, Marian Evatt, Camille P. Vaughan, Israt Jahan, Carlos Singer, Raul Ordorica, Jason L. Salemi, Jessica D. Shaw, Kelly L. Sullivan
Kelly L. Sullivan

URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo-Controlled Trial of Solifenacin succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Theresa Zesiewicz, Marian Evatt, Israt Jahan, Camille Vaughan, Carlos Singer, Raul Ordorica, Kelly Sullivan
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

An Open Label Study of Solifenacin Succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Israt Jahan, Camille Vaughan, Marian Evatt, Kelly Sullivan, Carlos Singer, Raul Ordorica, Theresa Zesiewicz
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

An Open Label Study of Solifenacin Succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Israt Jahan, Camille P. Vaughan, Marian Evatt, Kelly L. Sullivan, Carlos Singer, Raul Ordorica, Theresa A. Zesiewicz
Kelly L. Sullivan

URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo-Controlled Trial of Solifenacin succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Kelly L. Sullivan, Theresa A. Zesiewicz, Marian Evatt, Israt Jahan, Camille P. Vaughan, Carlos Singer, Raul Ordorica
Kelly L. Sullivan